CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Autologous fecal microbiota therapy +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02046525
NCT02046525Phase 2Completed
CompareCT.gov

Restoration of the Fecal Microbiome After Antimicrobial Exposure With Autologous Fecal Flora Restoration Therapy

Washington University School of Medicine·interventional·Posted Jan 27, 2014·Updated Jun 4, 2019

In Brief

A Phase 2 clinical trial evaluating Autologous fecal microbiota therapy and Placebo for Infectious Disease of Digestive Tract. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Ten healthy volunteers will be recruited to receive either an autologous stool transplant or a saline enema to determine if autologous fecal microbiota therapy will be able to rapidly, and safely, restore a patient's fecal microbiome after antimicrobial exposure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfectious Disease of Digestive Tract
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 27, 2014
Enrollment StartMar 1, 2014
Primary CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 12.4 years ago

Interventions

Autologous fecal microbiota therapybiological

Placeboother

Saline enema